A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome
- 1 December 1990
- journal article
- clinical trial
- Published by Springer Nature in Lung
- Vol. 168 (S1) , 864-869
- https://doi.org/10.1007/bf02718221
Abstract
Treatment with bovine surfactant (SF-RI 1) was shown to be efficacious in improving pulmonary function and in increasing survival rate without BPD in very premature infants. Surfactant therapy did not affect the risk of major complications of prematurity.Keywords
This publication has 17 references indexed in Scilit:
- A Multicenter Randomized, Placebo-Controlled Trial of Surfactant Therapy for Respiratory Distress SyndromeNew England Journal of Medicine, 1989
- Surfactant ReplacementAmerican Journal of Diseases of Children, 1988
- Efficacy and Standardisation of SF-RI 1: A Preparation from Bovine Lung SurfactantPublished by Springer Nature ,1988
- Surfactant for the Treatment of Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1987
- DOUBLE-BLIND CONTROLLED TRIAL OF SINGLE-DOSE TREATMENT WITH BOVINE SURFACTANT IN SEVERE HYALINE MEMBRANE DISEASEThe Lancet, 1987
- Prophylactic Treatment of Very Premature Infants with Human SurfactantNew England Journal of Medicine, 1986
- Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trialThe Journal of Pediatrics, 1985
- Clinical and Roentgenographic Scoring Systems for Assessing Bronchopulmonary DysplasiaArchives of Pediatrics & Adolescent Medicine, 1984
- Sonographic classification of intracranial hemorrhage. A prognostic indicator of mortality, morbidity, and short-term neurologic outcomeThe Journal of Pediatrics, 1982
- Prospective clinical comparison of two methods for mechanical ventilation of neonates: Rapid rate and short inspiratory time versus slow rate and long inspiratory timeThe Journal of Pediatrics, 1981